Bilal Hasdemir is a dedicated Content Writer with 5 years of professional…
View author profile →
Dr. Onur Yavuz is a graduate of Istanbul University - Cerrahpasa Faculty…
View profile →We review our content at regular intervals and update it whenever new research or a change in clinical guidelines requires it.
Overview
What Is Infiltrative Cardiomyopathy?
Infiltrative cardiomyopathy is a group of heart-muscle conditions in which abnormal material builds up in or between heart cells. The material may be an abnormal protein, mineral, iron, or other storage substance. These deposits can make the heart stiff, interfere with its electrical signals, or weaken its ability to pump. Symptoms and severity vary depending on the underlying disorder and how much of the heart is affected.
Symptoms
Symptoms
Symptoms depend on which parts of the heart are affected and on the underlying infiltrative disorder. A stiff heart may not fill normally, while weakened muscle may reduce blood flow; changes in the electrical system can also cause rhythm problems. Possible symptoms include:
- Shortness of breath (breathlessness)
- Fatigue
- Reduced ability to exercise
- Swelling of the legs or ankles (edema)
- Abdominal swelling or fullness
- Rapid heartbeat (tachycardia)
- Dizziness
- Fainting (syncope)
- Chest discomfort
Get urgent help
Some symptoms need immediate care
Sudden fainting, severe difficulty breathing, or sustained chest pain can signal a serious heart problem. Seek urgent medical attention if these symptoms occur.
Causes
Causes
Infiltrative cardiomyopathy occurs when abnormal material is deposited in, or replaces, heart tissue. This can change the heart muscle’s thickness and flexibility, disrupt electrical conduction, or reduce pumping ability. The cause may be inherited, related to an abnormal immune or blood-cell process, or acquired through iron or mineral accumulation.
| Underlying disorder | Material or mechanism | Possible cardiac effect |
|---|---|---|
| Amyloidosis | Abnormal amyloid proteins accumulate in tissues | Thick, stiff heart muscle, heart failure, or rhythm problems |
| Sarcoidosis | Clusters of inflammatory cells form in organs | Scarring that can cause weak pumping, arrhythmias, or conduction block |
| Iron overload | Excess iron is stored in heart cells | Dilated or weakened heart muscle and rhythm disturbances |
| Fabry disease | Inherited deficiency causes fatty material to accumulate in cells | Thickened heart muscle, stiffness, and electrical abnormalities |
| Storage disorders | Inherited problems cause minerals, fats, or other substances to build up | Heart thickening, impaired filling, or reduced pumping |
Infiltrative disorders affecting organs such as the liver do not automatically mean that the heart is involved. However, a systemic condition can affect both organs when the same abnormal protein, iron, inflammatory process, or storage material circulates through or accumulates in multiple tissues. This is why suspected hepatic infiltrative disease may require an assessment of other organs, including the heart.
Risk Factors
Risk Factors
Risk factors differ substantially because infiltrative disease can result from inherited conditions, aging, blood or inflammatory disorders, or acquired mineral and iron buildup. Family history and age cannot be changed, but several medical contributors can be treated or monitored. Having a risk factor does not mean that a person will develop heart involvement.
Nonmodifiable factors
These include a family history of infiltrative disease or an inherited mutation, as well as older age. Some inherited disorders, such as Fabry disease, can affect several generations and may require family evaluation.
Medical or acquired factors
Relevant factors include plasma-cell disorders, chronic inflammatory disease, repeated blood transfusions, kidney disease, and iron-loading conditions. Treating the underlying illness and monitoring iron or organ function may reduce the chance of progressive heart involvement.
Complications
Complications
- Heart failure can develop when the heart cannot fill or pump effectively.
- Abnormal heart rhythms may cause palpitations, dizziness, or fainting.
- Conduction block can slow or interrupt the electrical signal through the heart.
- Blood clots may form and travel to the brain, causing a stroke.
- Kidney or liver involvement may occur when the underlying disorder affects multiple organs.
- Some infiltrative disorders increase the risk of sudden cardiac death.
Deposits can make the heart stiff, reduce its pumping strength, or interfere with its electrical system. These changes may lead to fluid buildup, heart failure, dangerous rhythms, or clots. Whole-body complications, including kidney or liver problems, depend on the underlying cause. Risk varies with the disorder, the extent of heart involvement, and response to treatment.
Diagnosis
Diagnosis
Diagnosis usually combines a medical history, physical examination, blood and urine tests, an electrocardiogram (ECG), and heart imaging. Clinicians may also order targeted tests for the suspected systemic disorder, such as genetic or iron studies. The ICD-10 code for infiltrative cardiomyopathy depends on the specific underlying diagnosis and the cardiac manifestation, so there is not always one code for every case.
| Test | What it evaluates | Role in diagnosis |
|---|---|---|
| ECG | Heart rate, rhythm, and electrical conduction | May show low voltage, rhythm changes, or conduction block |
| Echocardiogram | Heart-wall thickness, filling, valves, and pumping | Assesses structure and function and looks for patterns suggesting infiltration |
| Cardiac MRI | Heart tissue characteristics, scarring, and function | Helps identify the location and pattern of abnormal tissue |
| Nuclear imaging | Tracer uptake by certain abnormal deposits | Can support evaluation for some forms of cardiac amyloidosis |
| Laboratory tests | Abnormal proteins, inflammation, iron, kidney function, and other markers | Helps identify systemic causes and assess organ involvement |
| Genetic testing | Inherited disease-causing variants | Useful when family history or a suspected inherited disorder is present |
| Biopsy | Actual material or tissue changes under a microscope | May confirm the diagnosis when noninvasive testing is inconclusive |
Clinicians distinguish amyloidosis, sarcoidosis, iron overload, Fabry disease, and other causes by combining targeted blood or urine tests with imaging patterns and the person’s medical and family history. Genetic testing may identify an inherited condition, while tissue sampling can confirm the deposited material when necessary. Testing is tailored to the suspected infiltrative disorder and the organs involved.
Treatment & Management
Treatment and Management
Treatment is individualized according to the infiltrative cause, the severity of heart involvement, organ function, symptoms, and genetic or systemic findings. The care plan may involve a cardiologist and specialists in blood disorders, inflammation, genetics, kidney disease, or other affected organs.
- Disease-specific medicines to reduce or control the abnormal protein, inflammation, iron, or storage material
- Treatment for plasma-cell disorders or inflammatory disease when these drive the heart involvement
- Diuretics and other supportive care to manage fluid overload and heart-failure symptoms
- Medicines or procedures to manage abnormal rhythms and conduction problems
- Anticoagulation when the risk of blood clots or stroke indicates it
- Referral for advanced therapies, such as specialized devices or transplant assessment, when appropriate
Ongoing monitoring and lifestyle support
Outlook and Prognosis
Outlook and Prognosis
The outlook for infiltrative cardiomyopathy varies widely. Some forms can be slowed or substantially improved when the underlying disease is treated early, while established damage to the heart may persist. Because this group includes many different disorders, a single survival estimate is not appropriate for everyone.
- The specific infiltrative disorder and whether it can be treated directly
- The degree of heart failure and damage to the heart muscle
- The presence of abnormal rhythms or conduction disease
- Kidney and liver function
- The response to disease-specific treatment
- Access to experienced cardiology and specialty care
When Should You See a Doctor
When Should You See a Doctor?
New or worsening shortness of breath, swelling, fatigue, palpitations, dizziness, or fainting should be evaluated by a clinician. Prompt review is especially important for anyone with amyloidosis, sarcoidosis, iron overload, a relevant inherited disorder, or a strong family history of heart disease. Early assessment may help identify treatable infiltrative heart disease before complications develop.
Emergency symptoms
Seek immediate medical care
Call emergency services for severe or sudden shortness of breath, chest pressure, fainting, new confusion, blue lips, or a sustained rapid or irregular heartbeat with symptoms. Also seek emergency help for signs of stroke, such as sudden facial drooping, arm weakness, or trouble speaking.
Branches
1 topic
Infiltrative Cardiomyopathy
Cardiology
